相关实验视频
Updated: May 7, 2026

07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
甲基生物素通过增强内皮细胞存活和再生来决定血管重塑
Ziad A Ali1, Ruth Rinze2, Gillian Douglas2
1Center for Interventional Vascular Therapy, Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY; Cardiovascular Research Foundation, New York, NY; Department of Cardiovascular Medicine, John Radcliffe Hospital and University of Oxford, Oxford, United Kingdom.
Circulation
|September 14, 2013
概括
向内皮GTP循环酶I可提高四水生物的水平,促进内皮细胞的再生,并减少血管损伤后的新极端增生.
科学领域:
- 血管生物学 血管生物学
- 再生医学是一种再生医学.
- 生物化学 生物化学
背景情况:
- 内皮细胞 (EC) 存活和再生对于血管损伤反应至关重要,影响新极端增生和动脉样硬化.
- 氧化 (NO) 调节EC和内皮原生细胞功能,但控制内皮NO合成酶在再生中的机制尚不清楚.
研究的目的:
- 调查内皮质四水生物在调节内皮质再生和新极度增生症中的作用.
- 为了确定是否向GTP循环酶I (GCH I) 可以增强血管损伤后的内皮功能.
主要方法:
- 在缺乏阿波利波蛋白E的小鼠中,GCH I的内皮向过度表达.
- 在实验性静脉移植中评估新极端增生症.
- 使用Tie2-LacZ记者小鼠进行追踪研究以评估EC存活率和重新繁殖.
主要成果:
- 过度表达GCH I增加了四二二的水平,特别是在EC中,减少了新极度增生症.
- 观察到GCH转基因EC的增强EC存活率和重新繁殖.
- 损伤后增加内皮 NO 合成酶合,EC 增殖和内皮原生细胞数量.
结论:
- 内皮四水生物的可用性通过促进EC的重新繁殖和生长来调节新极度增生.
- 针对四二二胺依赖的内皮NO合成酶调节是一种可行的治疗策略,用于血管损伤状态.
相关概念视频
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
